Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,98 € ↑2,18 (3,53%)
2026-06-04
CENA AKCJI
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionNorthern Trust Corp
Latest Disclosed Ownership643,158 shares
Latest Disclosed Value $ 25,925,699
Northern Trust Corp reports 2.24% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 643,158 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $22,182,519 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 629,075 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 2.24% during the quarter. The current value of the position is $41,149,249 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 643,158 14,083 2.24 25,926 18.43 0.0007
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 629,075 -13,251 -2.06 21,892 -58.99 0.0028
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 642,326 -9,977 -1.53 53,384 11.50 0.0068
2025-08-13 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 652,303 -369,698 -36.17 47,879 -58.98 0.0066
2025-05-13 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,022,001 6,486 0.64 116,733 128.12 0.0173
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,015,515 94,128 10.22 51,172 20.00 0.0072
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 921,387 -10,821 -1.16 42,642 40.79 0.0070
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 932,208 -31,235 -3.24 30,287 24.80 0.0051
2024-05-14 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 963,443 -128,055 -11.73 24,269 -31.54 0.0042
2024-02-13 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,091,498 -191,805 -14.95 35,452 1.40 0.0064
2023-11-13 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,283,303 -2,318 -0.18 34,964 22.23 0.0068
2023-08-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,285,621 -65,973 -4.88 28,605 -2.29 0.0055
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,351,594 327,128 31.93 29,276 40.70 0.0058
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,024,466 27,149 2.72 20,807 -18.64 0.0044
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 997,317 -176 -0.02 25,572 7.81 0.0058
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 997,493 -40,470 -3.90 23,720 1.47 0.0051
2022-05-13 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,037,963 -94,499 -8.34 23,376 4.25 0.0041
2022-02-08 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,132,462 -51,795 -4.37 22,422 -3.80 0.0037
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,184,257 -25,576 -2.11 23,307 -12.43 0.0041
2021-08-13 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,209,833 -34,919 -2.81 26,616 -10.12 0.0047
2021-05-12 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,244,752 -61,309 -4.69 29,613 -13.33 0.0055
2021-02-11 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,306,061 -27,683 -2.08 34,167 47.19 0.0067
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,333,744 -70,843 -5.04 23,213 -1.74 0.0051
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,404,587 93,569 7.14 23,624 51.55 0.0056
2020-05-14 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,311,018 19,718 1.53 15,588 -0.23 0.0045
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,291,300 -7,116 -0.55 15,624 -14.87 0.0035
2019-11-13 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,298,416 6,423 0.50 18,354 27.41 0.0044
2019-08-13 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,291,993 10,825 0.84 14,406 -4.22 0.0034
2019-05-13 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,281,168 -21,312 -1.64 15,040 -13.57 0.0037
2019-02-12 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,302,480 -8,956 -0.68 17,401 -5.36 0.0049
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,311,436 63,994 5.13 18,387 -6.24 0.0045
2018-09-18 2018-06-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 1,247,442 130,839 11.72 19,610 6.76 0.0050
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,254,798 138,195 19,726
2018-05-09 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,116,603 5,342 0.48 18,368 -8.48 0.0048
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,111,261 3,039 0.27 20,069 -6.17 0.0051
2017-11-13 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,108,222 20,295 1.87 21,388 66.60 0.0056
2017-08-11 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,087,927 164,732 17.84 12,838 26.90 0.0036
2017-05-12 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 923,195 52,274 6.00 10,117 60.00 0.0029
2017-02-13 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 870,921 14,623 1.71 6,323 13.60 0.0019
2016-11-09 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 856,298 19,929 2.38 5,566 21.87 0.0017
2016-08-12 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 836,369 121,955 17.07 4,567 36.61 0.0015
2016-08-19 2016-03-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 714,414 20,194 2.91 3,343 -3.30 0.0011
2016-05-13 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 714,414 3,343
2016-02-12 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 694,220 17,690 2.61 3,457 35.94 0.0011
2015-11-12 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 676,530 75,869 12.63 2,543 -29.56 0.0008
2015-08-13 2015-06-30 13F CORCEPT THERAPEUTICS COM 218352102 600,661 15,478 2.64 3,610 10.16 0.0024
2015-05-14 2015-03-31 13F CORCEPT THERAPEUTICS COM 218352102 585,183 11,482 2.00 3,277 90.41 0.0010
2015-02-12 2014-12-31 13F CORCEPT THERAPEUTICS COM 218352102 573,701 -26,875 -4.47 1,721 6.96 0.0005
2014-11-13 2014-09-30 13F CORCEPT THERAPEUTICS COM 218352102 600,576 -5,296 -0.87 1,609 -5.13 0.0005
2014-08-14 2014-06-30 13F CORCEPT THERAPEUTICS COM 218352102 605,872 -50,254 -7.66 1,696 -40.72 0.0005
2014-05-14 2014-03-31 13F CORCEPT THERAPEUTICS COM 218352102 656,126 -56,498 -7.93 2,861 25.04 0.0009
2014-02-21 2013-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 712,624 13,597 1.95 2,288 105.94 0.0007
2014-02-12 2013-12-31 13F CORCEPT THERAPEUTICS COM 218352102 712,624 2,288
2013-11-13 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 699,027 44,156 6.74 1,111 -1.94 0.0004
2013-08-09 2013-06-30 13F CORCEPT THERAPEUTICS COM 218352102 654,871 654,871 1,133 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.